Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01339871
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Active, not recruiting Phase I Study of Pazopanib and Vorinostat
Condition: Advanced Cancer
Interventions: Drug: Pazopanib;   Drug: Vorinostat

Study has passed its completion date and status has not been verified in more than two years.